The results of gene chip sequencing showed that the expression of XLOC-005590 and HNF1A-AS1 was upregulated in obese T2DM patients with dyslipidemia compared with that in healthy volunteers, and the downstream ECI2 expression was significantly downregulated. Here, HNF1A is linked to metabolic syndrome.